NL9000207A - - Google Patents
Info
- Publication number
- NL9000207A NL9000207A NL9000207A NL9000207A NL9000207A NL 9000207 A NL9000207 A NL 9000207A NL 9000207 A NL9000207 A NL 9000207A NL 9000207 A NL9000207 A NL 9000207A NL 9000207 A NL9000207 A NL 9000207A
- Authority
- NL
- Netherlands
- Prior art keywords
- intranasal
- formulation
- preparation
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nanotechnology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9000207A NL9000207A (xx) | 1990-01-29 | 1990-01-29 | |
IL9701491A IL97014A (en) | 1990-01-29 | 1991-01-24 | Liposome-containing intranasal vaccine formulation |
ZA91531A ZA91531B (en) | 1990-01-29 | 1991-01-24 | Liposome-containing intranasal vaccine formulation |
HU91256A HUT61204A (en) | 1990-01-29 | 1991-01-24 | Intranasal vaccine comprising liposome |
ES91200142T ES2082107T3 (es) | 1990-01-29 | 1991-01-25 | Formulacion de vacuna intranasal que contiene liposomas. |
DK91200142.7T DK0440289T3 (da) | 1990-01-29 | 1991-01-25 | Liposomholdig intranasal vaccineformulering |
EP91200142A EP0440289B1 (en) | 1990-01-29 | 1991-01-25 | Liposome-containing intranasal vaccine formulation |
AT91200142T ATE131723T1 (de) | 1990-01-29 | 1991-01-25 | Liposomenhaltige intranasale impfstofformulierung |
IE26891A IE74950B1 (en) | 1990-01-29 | 1991-01-25 | Liposome-containing intranasal vaccine formulation |
DE69115514T DE69115514T2 (de) | 1990-01-29 | 1991-01-25 | Liposomenhaltige intranasale Impfstofformulierung |
AU69990/91A AU647070B2 (en) | 1990-01-29 | 1991-01-25 | Liposome-containing intranasal vaccine formulation |
CA002035097A CA2035097A1 (en) | 1990-01-29 | 1991-01-28 | Liposome-containing intranasal vaccine formulation |
JP3026675A JP2997073B2 (ja) | 1990-01-29 | 1991-01-29 | 鼻腔内または吸入投与用ワクチン製剤およびその製造方法 |
US08/461,768 US5756104A (en) | 1990-01-29 | 1995-06-05 | Liposome-containing intranasal vaccine formulation |
GR960400619T GR3019213T3 (en) | 1990-01-29 | 1996-03-05 | Liposome-containing intranasal vaccine formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9000207A NL9000207A (xx) | 1990-01-29 | 1990-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL9000207A true NL9000207A (xx) | 1991-08-16 |
Family
ID=19856496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL9000207A NL9000207A (xx) | 1990-01-29 | 1990-01-29 |
Country Status (15)
Country | Link |
---|---|
US (1) | US5756104A (xx) |
EP (1) | EP0440289B1 (xx) |
JP (1) | JP2997073B2 (xx) |
AT (1) | ATE131723T1 (xx) |
AU (1) | AU647070B2 (xx) |
CA (1) | CA2035097A1 (xx) |
DE (1) | DE69115514T2 (xx) |
DK (1) | DK0440289T3 (xx) |
ES (1) | ES2082107T3 (xx) |
GR (1) | GR3019213T3 (xx) |
HU (1) | HUT61204A (xx) |
IE (1) | IE74950B1 (xx) |
IL (1) | IL97014A (xx) |
NL (1) | NL9000207A (xx) |
ZA (1) | ZA91531B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4136553A1 (de) * | 1991-11-06 | 1993-05-13 | Biotechnolog Forschung Gmbh | Impfstoff gegen schleimhauterreger und herstellungsverfahren |
DK17093D0 (da) * | 1993-02-15 | 1993-02-15 | Lyfjathroun H F | Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder |
GB9506863D0 (en) * | 1995-04-03 | 1995-05-24 | Smithkline Beecham Biolog | Vaccines |
EP1013269A4 (en) * | 1997-06-06 | 2002-02-20 | Shionogi & Co | IMPROVEMENT OF A DRUG ADMINISTRATION SYSTEM |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
PT1031347E (pt) * | 1999-01-27 | 2002-09-30 | Idea Ag | Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis |
US7442388B2 (en) * | 2000-05-10 | 2008-10-28 | Weers Jeffry G | Phospholipid-based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
BR0214279A (pt) * | 2001-11-19 | 2005-12-20 | Becton Dickinson Co | Composições farmacêuticas em forma particulada |
SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
BRPI0606481A2 (pt) | 2005-01-20 | 2009-06-30 | Isconova Ab | composição de vacina compreendendo uma proteìna de ligação a fibronectina ou um peptìdeo de ligação a fibronectina |
ES2272178B1 (es) * | 2005-09-19 | 2008-03-16 | Daniel Serrano Gil | Una composicion para ser administrada a un mamifero o a un ser humano. |
US20080033038A1 (en) * | 2006-07-07 | 2008-02-07 | Shytle R D | Compositions of polyphenols and methods of use |
LT2861214T (lt) * | 2012-06-14 | 2020-12-28 | Universität Bern | Specialiai pritaikytos liposomos, skirtos bakterinių infekcijų gydymui |
ES2442450B1 (es) * | 2012-08-09 | 2014-12-12 | Enoc Solutions, S.L. | Liposomas vacíos como adyuvante de diferentes principios activos, administrados independientemente y en su forma galénica convencional |
WO2015031536A1 (en) | 2013-08-27 | 2015-03-05 | Northeastern University | Nanoparticle drug delivery system and method of treating cancer and neurotrauma |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
US4148876A (en) * | 1975-09-29 | 1979-04-10 | Burroughs Wellcome Co. | Biological preparations |
US4196191A (en) * | 1975-09-29 | 1980-04-01 | Burroughs Wellcome Co. | Biological preparations |
US4323561A (en) * | 1977-09-06 | 1982-04-06 | Temple University Of The Commonwealth System Of Higher Education | Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants |
US4261975A (en) * | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
US4395394A (en) * | 1979-10-26 | 1983-07-26 | Pfizer Inc. | Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants |
US4310550A (en) * | 1979-10-26 | 1982-01-12 | Pfizer Inc. | Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants |
HU184141B (en) * | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
US4684625A (en) * | 1982-07-08 | 1987-08-04 | Syntex (U.S.A.) Inc. | Method for enhancing the anti-infective activity of muramyldipeptide derivatives |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4565696A (en) * | 1983-08-03 | 1986-01-21 | The Regents Of The University Of California | Production of immunogens by antigen conjugation to liposomes |
DE3410238A1 (de) * | 1984-03-21 | 1985-10-03 | Bayer Ag, 5090 Leverkusen | Glycolipid-aehnliche substanzen in liposomenform |
DE3412793A1 (de) * | 1984-04-05 | 1985-10-17 | Basotherm GmbH, 7950 Biberach | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
US5026557A (en) * | 1987-09-09 | 1991-06-25 | The Liposome Company, Inc. | Adjuvant composition |
FR2624741B1 (fr) * | 1987-12-21 | 1991-06-28 | Pasteur Institut | Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire |
EP0324455A3 (en) * | 1988-01-15 | 1991-03-27 | Hans O. Ribi | Novel polymeric immunological adjuvants |
NZ230424A (en) * | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
-
1990
- 1990-01-29 NL NL9000207A patent/NL9000207A/xx not_active Application Discontinuation
-
1991
- 1991-01-24 HU HU91256A patent/HUT61204A/hu unknown
- 1991-01-24 IL IL9701491A patent/IL97014A/en not_active IP Right Cessation
- 1991-01-24 ZA ZA91531A patent/ZA91531B/xx unknown
- 1991-01-25 DK DK91200142.7T patent/DK0440289T3/da active
- 1991-01-25 DE DE69115514T patent/DE69115514T2/de not_active Expired - Lifetime
- 1991-01-25 AT AT91200142T patent/ATE131723T1/de not_active IP Right Cessation
- 1991-01-25 EP EP91200142A patent/EP0440289B1/en not_active Expired - Lifetime
- 1991-01-25 IE IE26891A patent/IE74950B1/en not_active IP Right Cessation
- 1991-01-25 AU AU69990/91A patent/AU647070B2/en not_active Expired
- 1991-01-25 ES ES91200142T patent/ES2082107T3/es not_active Expired - Lifetime
- 1991-01-28 CA CA002035097A patent/CA2035097A1/en not_active Abandoned
- 1991-01-29 JP JP3026675A patent/JP2997073B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/461,768 patent/US5756104A/en not_active Expired - Lifetime
-
1996
- 1996-03-05 GR GR960400619T patent/GR3019213T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0440289B1 (en) | 1995-12-20 |
DK0440289T3 (da) | 1996-03-04 |
HU910256D0 (en) | 1991-08-28 |
HUT61204A (en) | 1992-12-28 |
GR3019213T3 (en) | 1996-06-30 |
JP2997073B2 (ja) | 2000-01-11 |
IL97014A0 (en) | 1992-03-29 |
ZA91531B (en) | 1991-10-30 |
IE74950B1 (en) | 1997-08-13 |
IL97014A (en) | 1995-01-24 |
DE69115514D1 (de) | 1996-02-01 |
DE69115514T2 (de) | 1996-06-05 |
EP0440289A1 (en) | 1991-08-07 |
CA2035097A1 (en) | 1991-07-30 |
US5756104A (en) | 1998-05-26 |
ES2082107T3 (es) | 1996-03-16 |
IE910268A1 (en) | 1991-07-31 |
ATE131723T1 (de) | 1996-01-15 |
AU647070B2 (en) | 1994-03-17 |
JPH04210925A (ja) | 1992-08-03 |
AU6999091A (en) | 1991-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL9000207A (xx) | ||
PL316199A1 (en) | Methods of and compositions for administering insulin into lungs | |
GR3025184T3 (en) | Vaccine composition containing adjuvants. | |
EP0653204A3 (en) | Aerosol formulations for medical use. | |
GR3022016T3 (en) | Transparent material for dental purposes | |
SG45288A1 (en) | Viral agent associated with swine disease | |
EP0636362A3 (en) | Use of soluble fluorinated surfactants in the preparation of compositions for metered-dose aerosol. | |
EP0734710A3 (en) | Medicament and support | |
EP0563311A4 (en) | Improved vaccines | |
EP0462534A3 (en) | Acellular anti-pertussis vaccines | |
IL96326A0 (en) | Polymyxin conjugates,their preparation and pharmaceutical compositions containing them | |
PH30098A (en) | 4,13-dioxabicyclo¬8.2.1¾ tridecenone compounds and pharmaceutical compositions containing them | |
NZ239281A (en) | Antigenic hiv conjugate, vaccine and pharmaceutical composition | |
EP0437729A3 (en) | New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses | |
EP0484403A4 (en) | Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines | |
EP0290565A4 (en) | VACCINE CONTAINING TICK ANTIGENS. | |
ZA892954B (en) | A synthetic vaccine against foot and mouth disease and a process for the preparation thereof | |
EP0565708A4 (en) | VACCINES USING LIPOSOMES, USED AGAINST MUCOSUS PATHOGENS. | |
GB8911259D0 (en) | Inhalation medicament | |
GR880300141T1 (en) | Bacterial antigenic lysate, a process for the preparation thereof and pharmaceutical compositions containing it | |
FR2671974B1 (xx) | ||
EP0505608A3 (en) | Alpha-dihydroergocryptine pharmaceutical preparations with neuroprotective acitivity | |
AU2715288A (en) | Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein | |
EP0563288A4 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines | |
ZA924670B (en) | Ccv vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1B | A search report has been drawn up | ||
BI | The patent application has been withdrawn |